Han, B. K., Kuzin, I., Gaughan, J. P., Olsen, N. J., & Bottaro, A. (2016). Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: A pilot, prospective study. Arthritis Res Ther.

Han, Bobby Kwanghoon, Igor Kuzin, John P. Gaughan, Nancy J. Olsen, và Andrea Bottaro. "Baseline CXCL10 and CXCL13 Levels Are Predictive Biomarkers for Tumor Necrosis Factor Inhibitor Therapy in Patients With Moderate to Severe Rheumatoid Arthritis: A Pilot, Prospective Study." Arthritis Res Ther 2016.

Han, Bobby Kwanghoon, et al. "Baseline CXCL10 and CXCL13 Levels Are Predictive Biomarkers for Tumor Necrosis Factor Inhibitor Therapy in Patients With Moderate to Severe Rheumatoid Arthritis: A Pilot, Prospective Study." Arthritis Res Ther 2016.